ACC akut 200mg cough reliever

ACC akut is a widely recognized over-the-counter mucolytic medication used to treat respiratory conditions characterized by thick mucus. The brand was originally established by Hexal AG, a German pharmaceutical company founded in 1986 by brothers Thomas and Andreas Strüngmann.

Historically, Hexal became a powerhouse in the generics market before being acquired by the Swiss multinational Novartis in 2005. Under Novartis, Hexal was integrated into Sandoz, their generics and biosimilars division. In late 2023, Sandoz was successfully spun off as an independent, publicly traded company. Consequently, the ultimate owner of the ACC brand as of 2026 is Sandoz Group AG, headquartered in Switzerland. While the product is a staple in German pharmacies and often manufactured at sites within Germany (such as the Salutas Pharma plants), its corporate ownership is now centered in Basel.